UKHSA has published its report ‘Hepatitis C in the UK 2023: Working to eliminate hepatitis C as a public health threat’. The report reviews the progress that has been made towards the WHO target of eliminating hepatitis C by 2030, and is based on data up to the end of 2021.
Resources
Drug services professional
Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country. Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.
Showing 11 to 20 of 321 resources
-
Hepatitis C in the UK 2023: Working to eliminate hepatitis C as a public health threat
UK, England, Northern Ireland, Scotland, Wales 03 Feb 2023 Reports & Research PDF -
HCV Action webinar summary report – Hepatitis C elimination initiatives: an overview
This webinar, which took place in December 2022, was organised by HCV Action in order to provide an overview of the NHS England hepatitis C 'elimination deal' and the activity that has taken place as part of it. The audience was primarily people who wished to have a more comprehensive understanding of the elimination deal and the various initiatives it launched to identify and treat undiagnosed patients. This summary report provides an overview of the key points from each of the webinar speakers.England 23 Jan 2023 Reports & Research, Strategy & Planning PDF -
Good practice case study: Targeted HCV testing in Bristol Emergency Department
The aim of the Emergency Department Peer Support Lead project is to improve the uptake of HCV testing in at-risk patients attending Bristol Royal Infirmary ED, using point-of-care testing on-site, conducted by the Hepatitis C Trust peer support worker and supported by the BRI hepatology team to provide treatment for any HCV-RNA positive patient identified within four weeks of a positive test.UK, England, South West 12 Jan 2023 Case study PDF -
Emergency department opt out testing for HIV, hepatitis B and hepatitis C: The first 100 days
This report from NHS England sets out learnings and results from the first 100 days of the emergency department opt out testing for HIV, hepatitis B and hepatitis C programme.England 29 Nov 2022 Reports & Research PDF -
Surveillance of hepatitis C in Scotland
This Public Health Scotland report provides an update on progress towards elimination of hepatitis C as a major public health concern in Scotland. The surveillance data suggests there has been major progress made on a number of hepatitis C elimination targets in Scotland.Scotland 08 Nov 2022 Reports & Research PDF -
ODN Event 2022: UK Health Security Agency update
The first talk of the day at October's HCV Action Hepatitis C ODN Stakeholder Event 2022, an update from UKHSA. Delivered by Dr Monica Desai, Consultant Epidemiologist and Head of Hepatitis C and Blood Borne Viruses/Infections at the UK Health Security Agency, and Dr Ruth Simmons, Epidemiologist at the UK Health Security Agency.England 31 Oct 2022 Reports & Research, Strategy & Planning Video -
ODN Event 2022: NHS England Elimination Programme Leads update
The second presentation of the HCV Action Hepatitis C ODN Stakeholder Event 2022 - updates from leads on the Elimination Programme. Presented by Prof Graham Foster, National Clinical Lead for ODNs at NHS England, and Mark Gillyon-Powell, Head of Programme – HCV Elimination at NHS England and NHS Improvement.England 31 Oct 2022 Reports & Research, Strategy & Planning Video -
ODN Event 2022: ODN perspective
The HCV Action Hepatitis C ODN Stakeholder Event 2022's third talk of the day, a presentation on the ODN perspective. Delivered by Sally Bufton, Hepatitis ODN Nurse/Manager at the Birmingham ODN, and Prof David Mutimer, Clinical Lead at the Birmingham ODN.England, West Midlands 31 Oct 2022 Reports & Research, Strategy & Planning Video -
ODN Event 2022: Maintaining elimination
The fourth presentation of the HCV Action Hepatitis C ODN Stakeholder Event 2022, on maintaining elimination. Delivered by Dr Doug MacDonald, Clinical Lead at the North Central London ODN.England 31 Oct 2022 Reports & Research, Strategy & Planning Video -
ODN Event 2022: Nurse perspective
The fifth talk of the day at the HCV Action Hepatitis C ODN Stakeholder Event 2022, this is a focus on the nurse perspective. Delivered by Helen Caldwell, a Hepatology Nurse Consultant at the Royal Liverpool and Broadgreen University Hospital NHS Trust.England 31 Oct 2022 Reports & Research, Strategy & Planning Video